Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
575 SEK | +3.23% |
|
+5.41% | +6.88% |
05-23 | Camurus' Rare Growth Disorder Drug Accepted for Review in EU | MT |
05-23 | Camurus Receives EMA Acceptance of MAA Filing for Octreotide SC Depot for the Treatment of Acromegaly | CI |
- Stock Market
- Equities
- CAMX Stock
- News Camurus AB
- Transcripts